| 1 |
-
Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis
-
8/27/2025 9:21:15 AM | Browse: 119 | Download: 168
|
| 2 |
-
Modern approach to hepatocellular carcinoma treatment
-
8/27/2025 9:21:10 AM | Browse: 79 | Download: 113
|
| 3 |
-
Biparametric magnetic resonance imaging-based radiomic and deep learning models for predicting Ki-67 risk stratification in hepatocellular carcinoma
-
8/27/2025 9:21:08 AM | Browse: 40 | Download: 119
|
| 4 |
-
Sex based relative expression of estrogen receptors and tumor necrosis factor-alpha in liver affects hepatitis C virus viral pathogenesis
-
8/27/2025 3:44:01 AM | Browse: 52 | Download: 89
|
| 5 |
-
Value of intravoxel incoherent motion and diffusion kurtosis imaging to differentiate hepatocellular carcinoma and intrahepatic cholangiocarcinoma
-
8/14/2025 5:49:32 AM | Browse: 25 | Download: 44
|
| 6 |
-
Advancing predictive oncology: Integrating clinical and radiomic models to optimize transarterial chemoembolization outcomes in hepatocellular carcinoma
-
8/7/2025 7:38:38 AM | Browse: 31 | Download: 41
|
| 7 |
-
Computed tomography-based deep learning and multi-instance learning for predicting microvascular invasion and prognosis in hepatocellular carcinoma
-
8/7/2025 6:39:59 AM | Browse: 30 | Download: 76
|
| 8 |
-
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy
-
8/7/2025 6:39:58 AM | Browse: 33 | Download: 67
|
| 9 |
-
Flotillin-1 promotes the progression of hepatocellular carcinoma by activating TFE3-mediated Golgi stress response via inhibition of mTORC1/2
-
8/5/2025 8:25:48 AM | Browse: 51 | Download: 110
|
| 10 |
-
Targeting tumor vascular endothelial cells for hepatocellular carcinoma treatment
-
8/5/2025 8:25:47 AM | Browse: 29 | Download: 72
|
| 11 |
-
Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management
-
7/25/2025 12:09:41 PM | Browse: 49 | Download: 78
|
| 12 |
-
Lifestyle factors in hepatocellular carcinoma: From pathogenesis to prognosis
-
7/22/2025 9:23:05 AM | Browse: 38 | Download: 98
|
| 13 |
-
Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence
-
7/14/2025 12:56:07 PM | Browse: 49 | Download: 143
|
| 14 |
-
Yttrium-90 microsphere therapy for hepatocellular carcinoma: Clinical efficacy, mechanistic insights, and comparative therapeutic perspectives
-
7/14/2025 12:55:58 PM | Browse: 39 | Download: 86
|
| 15 |
-
Integrating radiomics and machine learning for the diagnosis and prognosis of hepatocellular carcinoma
-
7/14/2025 12:55:51 PM | Browse: 41 | Download: 90
|
| 16 |
-
Exploring the impact of galectins on liver cancer: From immunopathogenesis to potential targets
-
7/4/2025 9:23:52 AM | Browse: 60 | Download: 196
|
| 17 |
-
Chromatin accessibility module identified by single-cell sequencing underlies the diagnosis and prognosis of hepatocellular carcinoma
-
6/26/2025 7:27:57 AM | Browse: 69 | Download: 260
|
| 18 |
-
Hepatocellular carcinoma in non-cirrhotic patients
-
6/20/2025 9:55:24 AM | Browse: 71 | Download: 197
|
| 19 |
-
Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapy
-
6/20/2025 8:05:12 AM | Browse: 64 | Download: 369
|
| 20 |
-
Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis
-
6/13/2025 1:39:48 PM | Browse: 51 | Download: 230
|
| 21 |
-
Preoperative model for predicting early recurrence in hepatocellular carcinoma patients using radiomics and deep learning: A multicenter study
-
6/13/2025 1:39:40 PM | Browse: 58 | Download: 392
|
| 22 |
-
Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma
-
6/13/2025 1:39:36 PM | Browse: 71 | Download: 285
|
| 23 |
-
Transarterial chemoembolization combined with lenvatinib vs transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
-
6/13/2025 1:39:35 PM | Browse: 58 | Download: 299
|
| 24 |
-
Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease
-
6/13/2025 1:39:34 PM | Browse: 61 | Download: 342
|
| 25 |
-
Regulator of chromosome condensation 1 promotes hepatocellular carcinoma proliferation via cell-division-cycle-associated-8 dependent phosphoinositide 3-kinase/protein kinase B signaling
-
6/13/2025 1:39:33 PM | Browse: 58 | Download: 320
|
| 26 |
-
Global scientific trends on hepatocellular carcinoma research from 2004 to 2023: A bibliometric and visualized analysis
-
6/13/2025 1:39:32 PM | Browse: 52 | Download: 300
|
| 27 |
-
Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA
-
6/6/2025 3:09:36 AM | Browse: 59 | Download: 279
|
| 28 |
-
Prediction of the efficacy of first transarterial chemoembolization for advanced hepatocellular carcinoma via a clinical-radiomics model
-
6/4/2025 7:41:48 AM | Browse: 58 | Download: 320
|
| 29 |
-
Analysis of risk factors for post-operative infection following drug-eluting trans arterial chemo embolization in hepatocellular carcinoma: A retrospective study
-
5/30/2025 10:57:34 AM | Browse: 74 | Download: 328
|
| 30 |
-
Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study
-
5/27/2025 7:04:46 AM | Browse: 66 | Download: 351
|
| 31 |
-
Multidisciplinary treatment strategies for the assessment of immune, coagulation, and biomarker responses after transarterial chemoembolization for hepatocellular carcinoma
-
5/23/2025 8:05:55 AM | Browse: 63 | Download: 305
|
| 32 |
-
Role of cell cycle-related gene SAC3 domain containing 1 as a potential target of nitidine chloride in hepatocellular carcinoma progression
-
5/20/2025 3:37:35 AM | Browse: 74 | Download: 302
|
| 33 |
-
Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, feces in hepatocellular carcinoma
-
5/15/2025 10:28:56 AM | Browse: 71 | Download: 286
|
| 34 |
-
Correlation between prognostic markers and clinical parameters in hepatocellular carcinoma: Pathophysiological aspects to therapeutic targets
-
5/15/2025 10:28:55 AM | Browse: 73 | Download: 235
|
| 35 |
-
Exploring the potential function of high expression of ANAPC1 in regulating ubiquitination in hepatocellular carcinoma
-
5/15/2025 10:28:54 AM | Browse: 79 | Download: 339
|
| 36 |
-
Prediction of Ki-67 expression in hepatocellular carcinoma with machine learning models based on intratumoral and peritumoral radiomic features
-
5/15/2025 10:28:50 AM | Browse: 75 | Download: 362
|
| 37 |
-
Multivariable prognostic models for post-hepatectomy liver failure: An updated systematic review
-
4/25/2025 8:23:00 AM | Browse: 80 | Download: 407
|
| 38 |
-
Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma
-
4/18/2025 7:43:22 AM | Browse: 95 | Download: 435
|
| 39 |
-
Modified LR-5 criteria based on gadoxetic acid can improve the sensitivity in the diagnosis of hepatocellular carcinoma
-
3/27/2025 2:18:05 AM | Browse: 92 | Download: 305
|
| 40 |
-
Long non-coding RNA in the regulation of cell death in hepatocellular carcinoma
-
3/26/2025 10:16:45 AM | Browse: 91 | Download: 300
|
| 41 |
-
Progress of research on glucose transporter proteins in hepatocellular carcinoma
-
3/26/2025 4:06:51 AM | Browse: 83 | Download: 244
|
| 42 |
-
MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma
-
3/25/2025 4:18:58 PM | Browse: 83 | Download: 389
|
| 43 |
-
Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma
-
3/25/2025 4:18:56 PM | Browse: 90 | Download: 449
|
| 44 |
-
Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment
-
3/25/2025 4:18:23 PM | Browse: 81 | Download: 371
|
| 45 |
-
Radiomics and clinicoradiological factors as a promising approach for predicting microvascular invasion in hepatitis B-related hepatocellular carcinoma
-
3/13/2025 10:10:59 AM | Browse: 111 | Download: 285
|
| 46 |
-
Treatment of intermediate-to-advanced unresectable hepatocellular carcinoma is shifting toward a multidisciplinary strategy that includes multiple modalities as needed
-
2/26/2025 4:21:43 AM | Browse: 89 | Download: 299
|
| 47 |
-
Advances in imaging techniques for tumor microenvironment evaluation in hepatocellular carcinoma
-
2/26/2025 4:21:42 AM | Browse: 103 | Download: 340
|
| 48 |
-
SEL1L-mediated endoplasmic reticulum associated degradation inhibition suppresses proliferation and migration in Huh7 hepatocellular carcinoma cells
-
2/26/2025 4:21:32 AM | Browse: 108 | Download: 455
|
| 49 |
-
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
-
2/26/2025 4:21:32 AM | Browse: 98 | Download: 347
|
| 50 |
-
Neoadjuvant therapy: Dawn of reducing the high post-surgery recurrence rate of hepatocellular carcinoma
-
2/24/2025 9:26:04 AM | Browse: 138 | Download: 439
|
